Sinofn Health
Sinofn Health
The global amino acids market is witnessing a paradigm shift from basic supplementation to functional "Smart Nutrition." As of 2024, the demand for high-purity, bioavailable amino acid derivatives in clinical nutrition (FSMP) and sports performance has reached an unprecedented CAGR of 8.2%. SINOFN Health sits at the nexus of this growth, bridging the gap between raw material synthesis and high-end consumer formulations.
Modern enterprises no longer seek just "suppliers"; they require "strategic manufacturing partners" who can navigate complex regulatory landscapes (FDA, EFSA, NMPA). Strategic sourcing now prioritizes supply chain transparency, carbon-neutral production, and molecular-level quality controlābenchmarks that SINOFN has integrated into its core operational DNA.
Beyond individual health, SINOFN addresses systemic challenges such as metabolic disorder management (e.g., Phenylketonuria) and geriatric sarcopenia. By providing stable, high-purity amino acid profiles, we enable global brands to launch products that serve medical-grade dietary requirements without compromising on sensory experience or cost-efficiency.
Science-Driven OEM for Global Supplement Brands
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group ā a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences (CAS). Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
During her clinical work, Mrs. Liu witnessed lifelong struggles of PKU (Phenylketonuria) children ā where specialized diets were financially out of reach. Driven to bridge this gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods.
"We measure success not just in revenue, but in lives improved through accessible science."
Our 2026-2030 roadmap focuses on the transition from traditional fermentation to precision bio-enzymatic synthesis. This method ensures 99.9% stereopurity of amino acids, reducing byproduct profile and enhancing metabolic absorption rates for the end consumer.
Led by Dr. Zhang Ying (CAS Postdoc), we are pioneering micro-encapsulation techniques that protect amino acids from gastric degradation, allowing for targeted release in the small intestine, thereby maximizing bioavailability by up to 40% compared to standard powders.
Utilizing big data from our PKU clinical studies, our R&D team employs AI modeling to predict the synergistic effects of various amino acid ratios with vitamins and minerals, optimizing formulas for specific user cohorts like "Active Aging" or "Cognitive Performance."
Medical Innovation Director (Peking Univ.)
R&D Lead (CAS Postdoc)
Formulation Director (Senior Scientist, NL)
10+ dedicated lines (softgels, gummies, powders). ISO 22000, HACCP, FSSC 22000 certified. Annual capacity: 500M+ units.
HPLC/GC-MS contaminant screening, microbiological safety testing, and stability/dissolution validation.
End-to-end batch tracking via blockchain technology, ensuring BRCGS-certified warehousing and transparent global shipping.
Navigating the complex FDA (USA), EFSA (Europe), and NMPA (China) requirements can be a barrier for brand expansion. SINOFN provides full regulatory dossier support, helping you secure necessary permits for FSMP and standard dietary supplements in over 40 countries.
Our production facilities are HALAL, KOSHER, and Vegan certified, ensuring your products meet the cultural and ethical demands of diverse global populations, including the rapidly growing Middle Eastern and Southeast Asian markets.
We are a CAS-backed entity, meaning our formulations are born from high-level academic research. Unlike standard OEM factories, we specialize in high-precision products like FSMP (Foods for Special Medical Purposes) and bioactive delivery systems.
Yes. Our Tianjin R&D center is equipped for pilot-scale prototyping (tablets, capsules, liquids). This allows startups to test market viability with smaller batches before moving to full-scale 500M+ unit production.
Absolutely. Our factory utilizes strictly segregated lines and advanced cleaning protocols (CIP) to prevent cross-contamination, essential for our PKU and medical-grade food production lines.
While our manufacturing is based in China, we have specialized logistics and compliance teams serving North America, the EU, Southeast Asia, and the Middle East.
SINOFN prioritizes intellectual property, holding 36 patents and 71 trademarks. We are certified with ISO9001, ISO22000, HACCP, and HALAL, demonstrating our commitment to quality and safety.
